(AZTA) Azenta - Ratings and Ratios

Azenta, Inc. (NASDAQ:AZTA) specializes in delivering advanced solutions for biological and chemical compound sample exploration and management, serving the global life sciences industry. The company operates through three core segments: Sample Management Solutions, Multiomics, and B Medical Systems. Its Sample Management Solutions segment offers a comprehensive suite of products and services, including automated storage systems, cryogenic solutions, and controlled rate thawing devices, alongside repository services and consultative support for experimental workflows. The Multiomics segment provides cutting-edge genomic and multiomic analysis services, including gene sequencing and synthesis editing. The B Medical Systems segment focuses on manufacturing and distributing temperature-controlled storage and transport solutions, primarily for healthcare and governmental organizations. Formerly known as Brooks Automation, Inc., the company rebranded as Azenta, Inc. in December 2021. Headquartered in Burlington, Massachusetts, Azenta has been a key player in the life sciences tools and services sector since its founding in 1978.

As of the latest data, Azenta, Inc. (NASDAQ:AZTA) is trading at $26.96 with a 20-day average volume of 852,810 shares. The stocks short-term trend indicates a potential downtrend, as the 20-day moving average (26.74) is below the 50-day moving average (34.26). The 200-day moving average (45.30) further suggests a longer-term downward trajectory. The Average True Range (ATR) of 1.91 indicates moderate volatility. From a fundamental perspective, the companys market capitalization stands at $1.24 billion, with a forward P/E ratio of 54.64, reflecting expectations of future earnings growth. The price-to-book ratio of 0.71 suggests undervaluation relative to its book value, while the price-to-sales ratio of 1.87 indicates modest revenue multiples. However, the negative return on equity (-9.41%) highlights current profitability challenges.

3-Month Forecast: Based on technical and fundamental analysis, Azenta, Inc. (NASDAQ:AZTA) is expected to face headwinds in the near term. The stocks downward momentum, indicated by the 20-day and 50-day moving averages, may persist, with potential support near $24.50. The ATR of 1.91 suggests price swings could remain moderate. On the fundamental side, while the forward P/E of 54.64 signals investor confidence in future growth, the current profitability metrics, including a negative RoE, may weigh on sentiment. The companys valuation multiples, particularly the P/B ratio of 0.71, could attract value investors, but the near-term outlook remains cautious.